Novartis' cancer treatment Kymriah gets Japan nod at cost of $305,800

United States News News

Novartis' cancer treatment Kymriah gets Japan nod at cost of $305,800
United States Latest News,United States Headlines
  • 📰 Reuters
  • ⏱ Reading Time:
  • 11 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 8%
  • Publisher: 97%

A Japanese government panel approved Novartis' cancer treatment Kymriah at ...

FILE PHOTO: Logo of Swiss drugmaker Novartis is seen at its branch in Schweizerhalle near Basel, Switzerland, March 29, 2018. REUTERS/Arnd Wiegmann/File Photo

The Swiss drugmaker aims to use the one-time personalized therapy in Japan for children and young people with acute lymphoblastic leukemia and adult patients with diffuse large B-cell lymphoma .

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Reuters /  🏆 2. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Justice Ruth Bader Ginsburg gets 'best fight' MTV Movie award nodJustice Ruth Bader Ginsburg gets 'best fight' MTV Movie award nodU.S. Supreme Court Justice Ruth Bader Ginsburg scored nominations on Tuesday for...
Read more »

Lawsuit accuses Gilead of propping up cost of lifesaving HIV treatments by blocking generic competitionLawsuit accuses Gilead of propping up cost of lifesaving HIV treatments by blocking generic competitionThe complaint names drugmakers Bristol-Myers Squibb and Johnson & Johnson subsidiary Janssen Pharmaceuticals as co-defendants.
Read more »

Stocks making the biggest moves premarket: Disney, Intel, Etsy, Fox Corp, Costco, Novartis & moreSome of the names on the move ahead of the open.
Read more »

Novartis buys Takeda's dry eye drug for $3.4 billionNovartis buys Takeda's dry eye drug for $3.4 billionSwiss drugmaker Novartis AG said on Wednesday it agreed to acquire Takeda Pharma...
Read more »

Takeda sells dry eye drug to Novartis to help cut debtTakeda sells dry eye drug to Novartis to help cut debtTakeda Pharmaceutical Co Ltd agreed to sell its dry eye drug to Swiss drugmaker ...
Read more »

Novartis vows to fight U.S. price-fixing claims against Sandoz unitNovartis vows to fight U.S. price-fixing claims against Sandoz unitNovartis on Monday said claims of price fixing against its Sandoz generics unit ...
Read more »

Brazil government, central bank nod to rapidly deteriorating GDP, fiscal positionBrazil government, central bank nod to rapidly deteriorating GDP, fiscal positionBrazil's government and central bank said the country's economic and f...
Read more »

Electronic implants studied for treatment of drug additionElectronic implants studied for treatment of drug additionSHANGHAI (AP) — Patient Number One is a thin man, with a scabby face and bouncy knees. His head, shaved in preparation for surgery, is wrapped in a clean, white cloth. Years of drug use cost...
Read more »

David Ortiz says he wouldn't visit White House because of Trump's treatment of immigrantsDavid Ortiz says he wouldn't visit White House because of Trump's treatment of immigrants'You don’t want to go and shake hands with a guy who is treating immigrants like (expletive),' Big Papi said.
Read more »



Render Time: 2025-02-24 19:55:56